Substituted amino heterocycles as VR1 antagonists for treating pain

Details for Australian Patent Application No. 2004213230 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Jones, Brian A.; Sparey, Timothy Jason; Brown, Rebecca Elizabeth; Burkamp, Frank; Doughty, Victoria Alexandra; Fletcher, Stephen Robert; Hollingworth, Gregory John

Agent Spruson & Ferguson

Pub. Number AU-A-2004213230

PCT Pub. Number WO2004/074290

Priority 0303910.4 20.02.03 GB

Filing date 20 February 2004

Wipo publication date 2 September 2004

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61P 025/04 Drugs for disorders of the nervous system

Event Publications

23 June 2005 PCT application entered the National Phase

  PCT publication WO2004/074290 Priority application(s): WO2004/074290

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213242-Triazole compounds useful in therapy

2004213229-Continuous extrusion apparatus